News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gentium S.p.A.'s Stem Cell Complication Drug Fails Trial


8/19/2009 6:43:31 AM

Bookmark and Share

Reuters -- Italian biopharmaceutical firm Gentium S.p.A. said its experimental drug to treat veno-occlusive disease, a complication of stem cell transplantation, missed the main goal of a late-stage study.

Read at Reuters
Read at Business Wire
Read at MSN
Read at Forbes


comments powered by Disqus
Reuters
Business Wire
MSN
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES